171 related articles for article (PubMed ID: 28148791)
1. Replication Capacity of Viruses from Acute Infection Drives HIV-1 Disease Progression.
Selhorst P; Combrinck C; Ndabambi N; Ismail SD; Abrahams MR; Lacerda M; Samsunder N; Garrett N; Abdool Karim Q; Abdool Karim SS; Williamson C
J Virol; 2017 Apr; 91(8):. PubMed ID: 28148791
[TBL] [Abstract][Full Text] [Related]
2. Subtype-Specific Differences in Gag-Protease-Driven Replication Capacity Are Consistent with Intersubtype Differences in HIV-1 Disease Progression.
Kiguoya MW; Mann JK; Chopera D; Gounder K; Lee GQ; Hunt PW; Martin JN; Ball TB; Kimani J; Brumme ZL; Brockman MA; Ndung'u T
J Virol; 2017 Jul; 91(13):. PubMed ID: 28424286
[TBL] [Abstract][Full Text] [Related]
3. Mother-to-Child HIV Transmission Bottleneck Selects for Consensus Virus with Lower Gag-Protease-Driven Replication Capacity.
Naidoo VL; Mann JK; Noble C; Adland E; Carlson JM; Thomas J; Brumme CJ; Thobakgale-Tshabalala CF; Brumme ZL; Brockman MA; Goulder PJR; Ndung'u T
J Virol; 2017 Sep; 91(17):. PubMed ID: 28637761
[TBL] [Abstract][Full Text] [Related]
4. Influence of Gag-protease-mediated replication capacity on disease progression in individuals recently infected with HIV-1 subtype C.
Wright JK; Novitsky V; Brockman MA; Brumme ZL; Brumme CJ; Carlson JM; Heckerman D; Wang B; Losina E; Leshwedi M; van der Stok M; Maphumulo L; Mkhwanazi N; Chonco F; Goulder PJ; Essex M; Walker BD; Ndung'u T
J Virol; 2011 Apr; 85(8):3996-4006. PubMed ID: 21289112
[TBL] [Abstract][Full Text] [Related]
5. Brief Report: Selection of HIV-1 Variants With Higher Transmission Potential by 1% Tenofovir Gel Microbicide.
Ngandu NK; Carlson JM; Chopera DR; Ndabambi N; Abdool Karim Q; Abdool Karim S; Williamson C
J Acquir Immune Defic Syndr; 2017 Sep; 76(1):43-47. PubMed ID: 28797020
[TBL] [Abstract][Full Text] [Related]
6. Lack of a significant impact of Gag-Protease-mediated HIV-1 replication capacity on clinical parameters in treatment-naive Japanese individuals.
Sakai K; Chikata T; Brumme ZL; Brumme CJ; Gatanaga H; Oka S; Takiguchi M
Retrovirology; 2015 Nov; 12():98. PubMed ID: 26585907
[TBL] [Abstract][Full Text] [Related]
7. High systemic levels of interleukin-10, interleukin-22 and C-reactive protein in Indian patients are associated with low in vitro replication of HIV-1 subtype C viruses.
Arias JF; Nishihara R; Bala M; Ikuta K
Retrovirology; 2010 Mar; 7():15. PubMed ID: 20211031
[TBL] [Abstract][Full Text] [Related]
8. A restriction enzyme based cloning method to assess the in vitro replication capacity of HIV-1 subtype C Gag-MJ4 chimeric viruses.
Claiborne DT; Prince JL; Hunter E
J Vis Exp; 2014 Aug; (90):. PubMed ID: 25225725
[TBL] [Abstract][Full Text] [Related]
9. No evidence for selection of HIV-1 with enhanced gag-protease or Nef function among breakthrough infections in the CAPRISA 004 tenofovir microbicide trial.
Chopera DR; Mann JK; Mwimanzi P; Omarjee S; Kuang XT; Ndabambi N; Goodier S; Martin E; Naranbhai V; Karim SA; Karim QA; Brumme ZL; Ndung'u T; Williamson C; Brockman MA;
PLoS One; 2013; 8(8):e71758. PubMed ID: 24015191
[TBL] [Abstract][Full Text] [Related]
10. Better Viral Control despite Higher CD4
El-Badry E; Macharia G; Claiborne D; Brooks K; Dilernia DA; Goepfert P; Kilembe W; Allen S; Gilmour J; Hunter E
J Virol; 2020 Jul; 94(16):. PubMed ID: 32461316
[TBL] [Abstract][Full Text] [Related]
11. In vitro characterization of multidrug-resistant HIV-1 isolates from a recently infected patient associated with dual tropism and rapid disease progression.
Mohri H; Markowitz M
J Acquir Immune Defic Syndr; 2008 Aug; 48(5):511-21. PubMed ID: 18645523
[TBL] [Abstract][Full Text] [Related]
12. Heterosexual Transmission of Subtype C HIV-1 Selects Consensus-Like Variants without Increased Replicative Capacity or Interferon-α Resistance.
Deymier MJ; Ende Z; Fenton-May AE; Dilernia DA; Kilembe W; Allen SA; Borrow P; Hunter E
PLoS Pathog; 2015 Sep; 11(9):e1005154. PubMed ID: 26378795
[TBL] [Abstract][Full Text] [Related]
13. Paediatric non-progression following grandmother-to-child HIV transmission.
Tsai MH; Muenchhoff M; Adland E; Carlqvist A; Roider J; Cole DK; Sewell AK; Carlson J; Ndung'u T; Goulder PJ
Retrovirology; 2016 Sep; 13(1):65. PubMed ID: 27608713
[TBL] [Abstract][Full Text] [Related]
14. Infection with multiple HIV-1 founder variants is associated with lower viral replicative capacity, faster CD4+ T cell decline and increased immune activation during acute infection.
Macharia GN; Yue L; Staller E; Dilernia D; Wilkins D; Song H; McGowan E; King D; Fast P; Imami N; Price MA; Sanders EJ; Hunter E; Gilmour J
PLoS Pathog; 2020 Sep; 16(9):e1008853. PubMed ID: 32886726
[TBL] [Abstract][Full Text] [Related]
15. Plasma Cytokine Levels in Chronic Asymptomatic HIV-1 Subtype C Infection as an Indicator of Disease Progression in Botswana: A Retrospective Case Control Study.
Iketleng T; Moyo S; Gaseitsiwe S; Nyombi B; Mitchell RM; Makhema J; Baum MK; Marlink R; Essex M; Musonda R
AIDS Res Hum Retroviruses; 2016 Apr; 32(4):364-9. PubMed ID: 26414751
[TBL] [Abstract][Full Text] [Related]
16. Deep Gene Sequence Cluster Analyses of Multi-Virus-Infected Mucosal Tissue Reveal Enhanced Transmission of Acute HIV-1.
Klein K; Nankya I; Nickel G; Ratcliff AN; Meadows AAJ; Hathaway N; Bailey JA; Stieh DJ; Cheeseman HM; Carias AM; Lobritz MA; Mann JFS; Gao Y; Hope TJ; Shattock RJ; Arts EJ
J Virol; 2021 Jan; 95(3):. PubMed ID: 33177204
[TBL] [Abstract][Full Text] [Related]
17. HIV-1 pol replication capacity predicts disease progression.
Daar ES; Kesler KL; Wrin T; Petropoulo CJ; Bates M; Lail A; Hellmann NS; Gomperts E; Donfield S;
AIDS; 2005 Jun; 19(9):871-7. PubMed ID: 15905667
[TBL] [Abstract][Full Text] [Related]
18. Consequences of HLA-B*13-Associated Escape Mutations on HIV-1 Replication and Nef Function.
Shahid A; Olvera A; Anmole G; Kuang XT; Cotton LA; Plana M; Brander C; Brockman MA; Brumme ZL
J Virol; 2015 Nov; 89(22):11557-71. PubMed ID: 26355081
[TBL] [Abstract][Full Text] [Related]
19. Increased replication of non-syncytium-inducing HIV type 1 isolates in monocyte-derived macrophages is linked to advanced disease in infected children.
Tuttle DL; Anders CB; Aquino-De Jesus MJ; Poole PP; Lamers SL; Briggs DR; Pomeroy SM; Alexander L; Peden KW; Andiman WA; Sleasman JW; Goodenow MM
AIDS Res Hum Retroviruses; 2002 Mar; 18(5):353-62. PubMed ID: 11897037
[TBL] [Abstract][Full Text] [Related]
20. HIV disease progression among women following seroconversion during a tenofovir-based HIV prevention trial.
Riddler SA; Husnik M; Ramjee G; Premrajh A; Tutshana BO; Pather A; Siva S; Jeenarain N; Nair G; Selepe P; Kabwigu S; Palanee-Phillips T; Panchia R; Mhlanga F; Levy L; Livant E; Patterson K; Elharrar V; Balkus J
PLoS One; 2017; 12(6):e0178594. PubMed ID: 28658251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
